Asisa Volz

2.4k total citations
60 papers, 1.4k citations indexed

About

Asisa Volz is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Asisa Volz has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 28 papers in Epidemiology and 19 papers in Virology. Recurrent topics in Asisa Volz's work include SARS-CoV-2 and COVID-19 Research (23 papers), Poxvirus research and outbreaks (18 papers) and Animal Virus Infections Studies (13 papers). Asisa Volz is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Poxvirus research and outbreaks (18 papers) and Animal Virus Infections Studies (13 papers). Asisa Volz collaborates with scholars based in Germany, Netherlands and United States. Asisa Volz's co-authors include Gerd Sutter, Robert Fux, Fei Song, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan, Sylvia Jany, Joost H. C. M. Kreijtz, Stephan Becker, Markus Eickmann and Bart L. Haagmans and has published in prestigious journals such as Science, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Asisa Volz

50 papers receiving 1.4k citations

Peers

Asisa Volz
Linda J. Rennick United States
Phillip L. Gomez United States
Chinglai Yang United States
Carissa Embury‐Hyatt Canada
Mara Battilani Italy
Robert W. Cross United States
Astrid Gall United Kingdom
Tatsunori Masatani Japan
Randall W. Renshaw United States
Juan García‐Arriaza Spain
Linda J. Rennick United States
Asisa Volz
Citations per year, relative to Asisa Volz Asisa Volz (= 1×) peers Linda J. Rennick

Countries citing papers authored by Asisa Volz

Since Specialization
Citations

This map shows the geographic impact of Asisa Volz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asisa Volz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asisa Volz more than expected).

Fields of papers citing papers by Asisa Volz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asisa Volz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asisa Volz. The network helps show where Asisa Volz may publish in the future.

Co-authorship network of co-authors of Asisa Volz

This figure shows the co-authorship network connecting the top 25 collaborators of Asisa Volz. A scholar is included among the top collaborators of Asisa Volz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asisa Volz. Asisa Volz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mayer, Leonie, Anahita Fathi, Maya Kono, et al.. (2024). MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans. npj Vaccines. 9(1). 20–20. 3 indexed citations
3.
Armando, Federico, et al.. (2024). Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19. Vaccines. 12(1). 52–52. 2 indexed citations
4.
Jany, Sylvia, Christine Brandmüller, Katharina Müller, et al.. (2024). Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study. International Journal of Molecular Sciences. 25(20). 10898–10898. 2 indexed citations
5.
Beythien, Georg, et al.. (2024). Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection. Viruses. 16(3). 417–417. 4 indexed citations
6.
7.
Kupke, Alexandra, Cornelius Rohde, Sylvia Jany, et al.. (2024). Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans. Vaccines. 12(12). 1316–1316. 2 indexed citations
8.
Rojas, Juan J., Lien Van Hoecke, Miquel À. Conesa, et al.. (2024). A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses. Molecular Therapy. 32(7). 2406–2422. 8 indexed citations
9.
Ciurkiewicz, Małgorzata, Kathrin Becker, Ingo Gerhauser, et al.. (2023). SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories. Veterinary Pathology. 61(2). 201–206. 4 indexed citations
10.
Langenmayer, Martin C., Lisa Marr, Sylvia Jany, et al.. (2023). Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice. Pathogens. 12(7). 867–867. 6 indexed citations
11.
George, Jeffy, Asisa Volz, Olusegun O. Onabajo, et al.. (2023). Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251. Nature Communications. 14(1). 1264–1264.
12.
Jany, Sylvia, Cornelius Rohde, Alexandra Kupke, et al.. (2023). Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice. Viruses. 15(5). 1180–1180. 6 indexed citations
13.
Kupke, Alexandra, Asisa Volz, Erik Dietzel, et al.. (2022). Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines. 10(4). 533–533. 10 indexed citations
14.
Volz, Asisa, et al.. (2021). Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Schnupfenvirus bei Kamelen und Zoonoseerreger. SHILAP Revista de lepidopterología. 134(3). 2 indexed citations
15.
Gerlach, Thomas, et al.. (2020). Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines. 8(3). 451–451. 58 indexed citations
16.
Wernike, Kerstin, Andrea Aebischer, Anna Michelitsch, et al.. (2020). Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals. Transboundary and Emerging Diseases. 68(4). 1779–1785. 64 indexed citations
17.
Kalinke, Ulrich, et al.. (2020). Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infection. Viruses. 12(1). 72–72. 6 indexed citations
18.
19.
20.
Ducatez, Mariette, Maxence Delverdier, Mattias Delpont, et al.. (2016). Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine. Veterinary Microbiology. 189. 59–67. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda J. Rennick Breakdown of academic impact, for papers by Phillip L. Gomez Breakdown of academic impact, for papers by Chinglai Yang Breakdown of academic impact, for papers by Carissa Embury‐Hyatt Breakdown of academic impact, for papers by Mara Battilani Breakdown of academic impact, for papers by Robert W. Cross Breakdown of academic impact, for papers by Astrid Gall Breakdown of academic impact, for papers by Tatsunori Masatani Breakdown of academic impact, for papers by Randall W. Renshaw Breakdown of academic impact, for papers by Juan García‐Arriaza
Rankless by CCL
2026